The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2016 | Prof. Hillmen on whether CLL is curable today
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses the debate ‘Can we cure CLL today?’ held at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. According to Prof Hillmen, the key question is how to define cure. He also discusses minimal residual disease (MRD) and the difference between measurable and unmeasurable MRD. Prof Hillmen argues that it is unlikely that many or any patients are being cured at the moment even though some patients may never relapse.
